AU2001266337A1 - Virus vector for transferring gene into renal cells - Google Patents
Virus vector for transferring gene into renal cellsInfo
- Publication number
- AU2001266337A1 AU2001266337A1 AU2001266337A AU6633701A AU2001266337A1 AU 2001266337 A1 AU2001266337 A1 AU 2001266337A1 AU 2001266337 A AU2001266337 A AU 2001266337A AU 6633701 A AU6633701 A AU 6633701A AU 2001266337 A1 AU2001266337 A1 AU 2001266337A1
- Authority
- AU
- Australia
- Prior art keywords
- virus vector
- renal cells
- transferring gene
- gene
- transferring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000197870 | 2000-06-27 | ||
JP2000-197870 | 2000-06-27 | ||
PCT/JP2001/005513 WO2002000264A1 (en) | 2000-06-27 | 2001-06-27 | Virus vector for transferring gene into renal cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001266337A1 true AU2001266337A1 (en) | 2002-01-08 |
Family
ID=18696137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001266337A Abandoned AU2001266337A1 (en) | 2000-06-27 | 2001-06-27 | Virus vector for transferring gene into renal cells |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030170897A1 (en) |
EP (1) | EP1297852A4 (en) |
KR (1) | KR20030014392A (en) |
CN (1) | CN1281276C (en) |
AU (1) | AU2001266337A1 (en) |
CA (1) | CA2414077A1 (en) |
HK (2) | HK1052140A1 (en) |
WO (1) | WO2002000264A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016539A1 (en) * | 1995-11-01 | 1997-05-09 | Dnavec Research Inc. | Recombinant sendai virus |
US6490775B1 (en) * | 1999-04-23 | 2002-12-10 | Veri-Tek Inc. | Press operation verification system |
US20030166252A1 (en) * | 1999-05-18 | 2003-09-04 | Kaio Kitazato | Paramyxovirus-derived RNP |
US7226786B2 (en) * | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
ATE369435T1 (en) | 1999-09-06 | 2007-08-15 | Dnavec Research Inc | PARAMYXOVIRUSES COMPRISING A MODIFIED TRANSCRIPTION START SEQUENCE |
US7314614B1 (en) | 1999-11-02 | 2008-01-01 | Dnavec Research, Inc. | Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
EP1251174A4 (en) * | 2000-01-19 | 2003-05-02 | Dnavec Research Inc | Use of paramyxovirus vector in gene transfer into blood vessel |
AU2001244675A1 (en) * | 2000-03-30 | 2001-10-08 | Dnavec Research Inc. | Aids virus vaccine with the use of sendai virus vector |
AU2001262684A1 (en) * | 2000-06-01 | 2001-12-11 | Dnavec Research Inc. | Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
JP2002142770A (en) * | 2000-11-08 | 2002-05-21 | Dnavec Research Inc | Paramyxovirus vector for transporting gene to circulatory system |
WO2002083185A1 (en) * | 2001-04-06 | 2002-10-24 | Chugai Seiyaku Kabushiki Kaisha | Method of gene transfer via vascular system or ureter |
EP1504766A4 (en) * | 2002-04-30 | 2006-11-02 | Dnavec Research Inc | Drug- or gene-carrier composition having lowered hemagglutinin activity |
US20060128019A1 (en) * | 2002-09-04 | 2006-06-15 | Masanori Kobayashi | Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase |
AU2003275581A1 (en) * | 2002-10-24 | 2004-05-13 | Dnavec Research Inc. | Method of transferring gene into t cells |
WO2004067752A1 (en) * | 2003-01-31 | 2004-08-12 | Dnavec Research Inc. | Paramyxovirus vector encoding ribozyme and utilization thereof |
US20070105208A1 (en) * | 2003-06-30 | 2007-05-10 | Jun You | Minus strand rna virus vector carrying gene modified in high mutation region |
US20070141705A1 (en) * | 2004-01-22 | 2007-06-21 | Makoto Inoue | Method for producing viral vectors |
US20090162320A1 (en) | 2005-10-28 | 2009-06-25 | Dnavec Corporation | Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
US9259445B2 (en) * | 2006-06-07 | 2016-02-16 | Universidad Tecnica Federico Santa Maria | Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure |
JP2009079042A (en) * | 2007-09-07 | 2009-04-16 | Univ Nagoya | Recombinant vector for treatment of nephrogenic diabetes insipidus, and use thereof |
WO2013166378A1 (en) * | 2012-05-03 | 2013-11-07 | Indiana University Research And Technology Corporation | Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods |
US10980985B2 (en) | 2013-08-30 | 2021-04-20 | Indiana University Research And Technology Corporation | Hydrodynamic method and apparatus for delivering fluids to kidney tissues |
JP6854461B2 (en) * | 2014-11-05 | 2021-04-07 | 国立大学法人九州大学 | Viral vector, iPS cell preparation method and construct |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
GB202217332D0 (en) * | 2022-11-18 | 2023-01-04 | Univ Bristol | Methods |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0864645B9 (en) * | 1995-10-31 | 2006-03-22 | Dnavec Research Inc. | Negative-strand rna virus vector having autonomously replicating activity |
WO1997016539A1 (en) * | 1995-11-01 | 1997-05-09 | Dnavec Research Inc. | Recombinant sendai virus |
JP3883213B2 (en) * | 1998-07-03 | 2007-02-21 | 株式会社ディナベック研究所 | (−) Strand RNA viral vector for nerve cells |
US6828138B1 (en) * | 1998-08-11 | 2004-12-07 | Dnavec Research Inc. | Recombinant sendai virus vector including a gene encoding a chemokine |
US20020169306A1 (en) * | 1999-05-18 | 2002-11-14 | Kaio Kitazato | Envelope gene-deficient paramyxovirus vector |
US20030022376A1 (en) * | 1999-05-18 | 2003-01-30 | Kaio Kitazato | Paramyxovirus-derived RNP |
US20030166252A1 (en) * | 1999-05-18 | 2003-09-04 | Kaio Kitazato | Paramyxovirus-derived RNP |
US7226786B2 (en) * | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
ATE369435T1 (en) * | 1999-09-06 | 2007-08-15 | Dnavec Research Inc | PARAMYXOVIRUSES COMPRISING A MODIFIED TRANSCRIPTION START SEQUENCE |
EP1251174A4 (en) * | 2000-01-19 | 2003-05-02 | Dnavec Research Inc | Use of paramyxovirus vector in gene transfer into blood vessel |
AU769385C (en) * | 2000-02-02 | 2004-07-29 | Genomldea Inc. | Virus envelope vector for gene transfer |
AU2001244675A1 (en) * | 2000-03-30 | 2001-10-08 | Dnavec Research Inc. | Aids virus vaccine with the use of sendai virus vector |
CA2322057A1 (en) * | 2000-05-18 | 2001-11-18 | Dnavec Research Inc. | Paramyxovirus vectors used for transfer of foreign genes |
AU2001262684A1 (en) * | 2000-06-01 | 2001-12-11 | Dnavec Research Inc. | Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
CA2424992A1 (en) * | 2000-10-06 | 2003-04-04 | Dnavec Research Inc. | Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
JP2002142770A (en) * | 2000-11-08 | 2002-05-21 | Dnavec Research Inc | Paramyxovirus vector for transporting gene to circulatory system |
JP4212357B2 (en) * | 2000-11-27 | 2009-01-21 | 株式会社ディナベック研究所 | Paramyxovirus vectors encoding angiogenic genes and uses thereof |
-
2001
- 2001-06-27 US US10/312,476 patent/US20030170897A1/en not_active Abandoned
- 2001-06-27 EP EP01943839A patent/EP1297852A4/en not_active Withdrawn
- 2001-06-27 AU AU2001266337A patent/AU2001266337A1/en not_active Abandoned
- 2001-06-27 WO PCT/JP2001/005513 patent/WO2002000264A1/en not_active Application Discontinuation
- 2001-06-27 CN CNB018141439A patent/CN1281276C/en not_active Expired - Fee Related
- 2001-06-27 KR KR1020027017687A patent/KR20030014392A/en not_active Application Discontinuation
- 2001-06-27 CA CA002414077A patent/CA2414077A1/en not_active Abandoned
-
2003
- 2003-06-18 HK HK03104402.1A patent/HK1052140A1/en unknown
- 2003-12-16 HK HK03109177A patent/HK1056693A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1052140A1 (en) | 2003-09-05 |
CN1281276C (en) | 2006-10-25 |
EP1297852A1 (en) | 2003-04-02 |
EP1297852A4 (en) | 2004-12-29 |
HK1056693A1 (en) | 2004-02-27 |
CA2414077A1 (en) | 2002-01-03 |
WO2002000264A1 (en) | 2002-01-03 |
US20030170897A1 (en) | 2003-09-11 |
KR20030014392A (en) | 2003-02-17 |
CN1447700A (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001266337A1 (en) | Virus vector for transferring gene into renal cells | |
AU769385C (en) | Virus envelope vector for gene transfer | |
AU2001280835A1 (en) | Value transfer system for unbanked customers | |
AU2001259266A1 (en) | System for functional gene discovery in plants | |
AU2001286643A1 (en) | Gene discovery using microarrays | |
AU2001291656A1 (en) | Gene silencing vector | |
AU2744901A (en) | Cooperative error handling system | |
AU5215601A (en) | Inflammation-related gene | |
AU2001290273A1 (en) | Paramyxovirus vector for transferring foreign gene into skeletal muscle | |
AU3758199A (en) | Peptides for efficient gene transfer | |
AU2001289943A1 (en) | Complexes for transferring nucleic acids into cells | |
AU2001242625A1 (en) | Gene sequence | |
AU2001245700A1 (en) | Transfer microdissection | |
AU2001264247A1 (en) | GASC1 gene | |
AU7318700A (en) | Novel transaldolase gene | |
AUPQ749100A0 (en) | New epilespy gene | |
AU2472501A (en) | Methods for protein transfer | |
AU2001247444A1 (en) | Erbeta-mediated gene expression | |
AU2001285743A1 (en) | Adipose-related gene | |
AU7567101A (en) | Gene expression system | |
AUPQ521300A0 (en) | Improved kit handling system | |
AU2001296607A1 (en) | High efficiency regulatable gene expression system | |
AU2001255311A1 (en) | Herpes virus complementing cell line | |
AU1870000A (en) | Gene therapy-2 | |
AU6871900A (en) | Tsg-like gene |